PTNM home face


PTNM may provide relief from your overactive bladder symptoms.

Regain control
with PTNM

As someone affected by overactive bladder (OAB), you know how much it can interrupt your life. You worry about accidents. Avoid social situations. And limit your activities.

It doesn’t have to be this way.

You have options. One of them is Medtronic Bladder Control Therapy delivered by the NURO™ System. Also called percutaneous tibial neuromodulation or PTNM, this therapy restores bladder function* so you can get back to the life you enjoy.

I want to learn about my OAB treatment options.

I’ve already scheduled or started receiving PTNM.

people icon

You are not alone

Overactive bladder (OAB) affects 1 in 6 people and more than 37 million Americans.1,2

Confident control,
every day

PTNM is a safe and effective OAB treatment that’s clinically proven to restore* bladder function.3-5

PTNM smiley icon

Significantly improves quality of life4-8

PTNM Chart Icon

Reduces urgency, frequency, and accidents5

PTNM Calc Icon

Provides lasting relief with maintenance therapy8

PTNM Pill Icon

Doesn't have the side effects of medication**

PTNM home middle

What’s different
about PTNM?

If you’ve tried OAB treatments and haven’t been happy with the results, don’t give up. These treatments may not have addressed the miscommunication between the brain and bladder that is thought to be linked to OAB.

PTNM uses neuromodulation to reset brain-bladder communication and restore bladder function.*

Learn how PTNM works.

PTNM Product Image
* Restored function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment
** Most common side effects are temporary and include mild pain or skin inflammation at or near the stimulation site.

“I gave up after meds didn’t work…I had no idea these other options existed.”

— Lori, receiving bladder control therapy with percutaneous tibial neuromodulation (PTNM)

Learn about OAB treatment options


  1. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-336.
  2. United Nations Department of Economic and Social Affairs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition.
  3. Govier FE, Litwiller S, Nitti V, et al. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165(4):1193-1198.
  4. Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182(3):1055-1061.
  5. Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438-1443.
  6. Bellette PO, Rodrigues-Palma PC, Herman V, et al. Posterior tibial nerve stimulation in the management of overactive bladder: a prospective and controlled study. Actas Urol Esp. 2009;33(1):58-63.
  7. Finazzi-Agrò E, Petta F, Sciobica F, et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol. 2010;184(5):2001-2006.
  8. Peters KM, Carrico DJ, Wooldridge LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194-2201.